Literature DB >> 2531862

Reversible obstructive hypertrophic cardiomyopathy in the Beckwith-Wiedemann syndrome.

C A Ryan1, M H Boyle, G W Burggraf.   

Abstract

Patients with the Beckwith-Wiedemann (B-W) syndrome have been reported to have an increased risk of congenital heart disease and of idiopathic cardiomegaly on chest x-ray. In the infant described here, reversible obstructive hypertrophic cardiomyopathy was documented and its relationship to the metabolic features of the B-W syndrome is discussed.

Entities:  

Mesh：

Year:  1989        PMID： 2531862     DOI： 10.1007/BF02083298

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  10 in total

1.  Hypertrophic cardiomyopathy in total lipodystrophy: insulin action in the face of insulin resistance?

Authors:  M E Geffner; T V Santulli; S A Kaplan
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

2.  Hypertrophic cardiomyopathy in total lipodystrophy.

Authors:  K S Rheuban; R M Blizzard; M A Parker; T Carter; T Wilson; H P Gutgesell
Journal:  J Pediatr       Date:  1986-08       Impact factor: 4.406

3.  Metabolic aspects of the Beckwith-Wiedemann syndrome.

Authors:  D Schiff; E Colle; D Wells; L Stern
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

4.  Hypertrophic cardiomyopathy in a midtrimester fetus born to a diabetic mother.

Authors:  J Leslie; S C Shen; L Strauss
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

5.  Normal dosage of the insulin and insulin-like growth factor II genes in patients with the Beckwith-Wiedemann syndrome.

Authors:  R A Spritz; D Mager; R M Pauli; R Laxova
Journal:  Am J Hum Genet       Date:  1986-08       Impact factor: 11.025

6.  Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome.

Authors:  M Waziri; S R Patil; J W Hanson; J A Bartley
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

7.  Leprechaunism: in vitro insulin action despite genetic insulin resistance.

Authors:  M E Geffner; S A Kaplan; N Bersch; B M Lippe; W G Smith; R A Nagel; T V Santulli; C H Li; D W Golde
Journal:  Pediatr Res       Date:  1987-09       Impact factor: 3.756

8.  Cardiac septal hypertrophy in hyperinsulinemic infants.

Authors:  J A Breitweser; R A Meyer; M A Sperling; R C Tsang; S Kaplan
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

9.  Characterization of the cardiomyopathy in infants of diabetic mothers.

Authors:  H P Gutgesell; M E Speer; H S Rosenberg
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

10.  Cardiovascular abnormalities in the Beckwith-Wiedemann syndrome.

Authors:  R D Greenwood; A Somer; A Rosenthal; J Craenen; A S Nadas
Journal:  Am J Dis Child       Date:  1977-03
  10 in total
  4 in total

1.  Cardiac pathologies in mouse loss of imprinting models are due to misexpression of H19 long noncoding RNA.

Authors:  Ki-Sun Park; Beenish Rahat; Hyung Chul Lee; Zu-Xi Yu; Jacob Noeker; Apratim Mitra; Connor M Kean; Russell H Knutsen; Danielle Springer; Claudia M Gebert; Beth A Kozel; Karl Pfeifer
Journal:  Elife       Date:  2021-08-17       Impact factor: 8.713

2.  Discrete subvalvular aortic stenosis in the Beckwith-Wiedemann syndrome.

Authors:  J Shirani; K Natarajan; P Varga; D A Vitullo
Journal:  Pediatr Cardiol       Date:  1993-07       Impact factor: 1.655

3.  The incidence of cardiac lesions in infants born with major gastrointestinal malformations in Northern Ireland.

Authors:  A J Thompson; H C Mulholland
Journal:  Ulster Med J       Date:  2000-05

4.  Three patients presenting with severe macrosomia and congenital hypertrophic cardiomyopathy: a case series.

Authors:  Marie Vincent; Nadir Benbrik; Bénédicte Romefort; Agnès Colombel; Stéphane Bézieau; Bertrand Isidor
Journal:  J Med Case Rep       Date:  2017-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.